Welcome to Tip’d, a social media site for finance, investing, and business topics. Want to participate? » Join Tip’d now! or read our FAQ.
Aethlon Medical, Inc. (OTCBB: AEMD) reports it has submitted a request to the U.S. Food and Drug Administration (FDA) for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier®
Save & Share
Spam? Topple this!
Save & Share
Spam? Topple this!
investid
Comments
Want to leave a comment on this story? Login or join Tip'd to comment.